Fate Therapeutics, Inc. (FRA:F6T)
0.8962
+0.0580 (6.92%)
At close: Dec 4, 2025
-67.89% (1Y)
| Market Cap | 108.81M |
| Revenue (ttm) | 6.08M |
| Net Income (ttm) | -133.04M |
| Shares Out | n/a |
| EPS (ttm) | -1.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 8 |
| Open | 0.8962 |
| Previous Close | 0.8382 |
| Day's Range | 0.8962 - 0.8962 |
| 52-Week Range | 0.6004 - 2.5440 |
| Beta | n/a |
| RSI | 46.39 |
| Earnings Date | Nov 20, 2025 |